Completed
HIV Treatment and CVD Events
NCT01054638
- Conditions
- Acquired Immunodeficiency Syndrome, Acute Myocardial Infarction, Blood-Borne Infections, +18 more
- Locations
-
Not specified
Clinical trial condition
HIV Infection
Explore clinical trials studying HIV Infection. Study availability and eligibility vary by location and protocol.
540 public trials
23 recruiting studies
HIV Infection trial results
Completed
Zambia Exclusive Breastfeeding Study
NCT00310726
- Conditions
- Behavior, Blood-Borne Infections, Breast Feeding, +15 more
- Locations
-
- George and Chawama District Health Clinics Lusaka, Zambia
NCT00367952
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
- Locations
-
- Avexa (co-ordinating sites in Australia and Argentina) Melbourne, Victoria, Australia
NCT00352066
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Jasper Clinic Inc Kalamazoo, Michigan, United States
Completed
Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients
NCT00481390
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +14 more
- Locations
-
- GSK Investigational Site Helsinki, Finland
- GSK Investigational Site Dublin, Ireland
- GSK Investigational Site Alkmaar, Netherlands
- GSK Investigational Site Amsterdam, Netherlands
Completed
TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial
NCT00111280
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
- Locations
-
Not specified
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
- Locations
-
Not specified
NCT00141284
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +18 more
- Locations
-
- Pfizer Investigational Site Bakersfield, California, United States
- Pfizer Investigational Site Miami, Florida, United States
- Pfizer Investigational Site Shreveport, Louisiana, United States
- Pfizer Investigational Site Dallas, Texas, United States
Completed
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
NCT00085943
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Sacramento, California, United States
NCT00246610
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
- Locations
-
- Pfizer Investigational Site Jacksonville, Florida, United States
- Pfizer Investigational Site Miami, Florida, United States
- Pfizer Investigational Site Metairie, Louisiana, United States
- Pfizer Investigational Site Detroit, Michigan, United States